Low-Dose Naltrexone for Cancer Pain: Dosing, Evidence, and Safety with Chemotherapy and Hormonal Therapies
Low-dose naltrexone (LDN) is being studied off-label for refractory cancer-related pain. This article reviews typical dosing, early clinical evidence, and key safety considerations for people on chemotherapy or hormonal therapy.
